CBD for Horses: Does It Actually Work?

Horses have an endocannabinoid system (ECS) with CB1 receptors in the nervous system and CB2 receptors in immune tissues throughout the body. CBD doesn't bind directly to these receptors the way THC does — instead it inhibits the enzyme that breaks down the horse's own endocannabinoids, allowing them to remain active longer. It also interacts with TRPV1 (pain/temperature) and serotonin receptors. This multi-pathway mechanism is why CBD shows potential for chronic inflammation, anxiety, and pain management. Research specific to horses is still limited, but the underlying mechanism is well-established across mammalian species.

No FDA-approved standardized dosing exists for equine CBD. Current practitioner consensus is to start at 0.1–0.25mg of CBD per kilogram of body weight daily — for a 500kg (1,100 lb) horse, that's roughly 50–125mg/day as a starting dose. Maintenance doses commonly range from 100–200mg/day. Start low, assess over 14–21 days, then adjust upward if needed. Always follow the specific product's feeding directions and consult your veterinarian, particularly if your horse is on other medications.

Full-spectrum contains all hemp compounds including trace THC (≤0.3%) — most potentially effective but highest drug test risk. Broad-spectrum removes THC while preserving other cannabinoids and terpenes — middle ground for horses not competing under USEF/FEI but possibly in other tested events. CBD isolate is pure CBD only — lowest drug test risk but potentially less effective. For strictly non-competition horses, full-spectrum is most widely used. Regardless of type, CBD remains prohibited by USEF, FEI, and most governing bodies at any time.

Yes — CBD and all cannabinoids are prohibited by USEF, FEI, AQHA, APHA, NRHA, AERC, and most major equine governing bodies. USEF and FEI prohibit CBD at any time, not just on competition days. AQHA and most breed organizations test on competition day only. There is no safe withdrawal period under USEF/FEI rules because the prohibition is rules-based, not purely threshold-based. CBD is only appropriate for horses definitively not competing under these organizations.

A COA is a third-party lab report verifying what a product contains. Check five things: (1) Cannabinoid panel — CBD content should match the label within ±5%, THC should be ≤0.3% or non-detectable. (2) Heavy metals panel — lead, arsenic, mercury, and cadmium must be non-detectable. (3) Pesticide panel — all agricultural chemicals should be ND or below action limits. (4) Microbial panel — no mold, E. coli, or salmonella. (5) Lab independence — the lab must be ISO/IEC 17025 accredited and independent from the manufacturer. Never buy without a current, publicly accessible COA.

CBD supplements do not affect equine insurance premiums, eligibility, or coverage. Insurers don't ask about supplement use at underwriting. For non-competition horses, there is zero insurance implication from CBD use. The only indirect insurance risk applies to competition horses: if a USEF or FEI horse tests positive for cannabinoids in violation of competition rules, any resulting suspension or impact on the horse's competition value could indirectly affect claims related to loss of use or performance value — but the policy itself is not voided.

Not recommended. Human and dog CBD products are formulated for very different body weights — dosing a 1,100 lb horse with human-grade products would be impractical and expensive. More importantly, some human CBD products contain additives (flavorings, sweeteners including xylitol, carrier oils) that may not be appropriate for horses. Always use equine-specific products formulated and dosed for horses, with COAs confirming they are free of inappropriate additives.